The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

ProMetic Life Sciences Inc

TSX: PLI
Delayed quote

$2.08

Today's change-0.01 -0.48%
Updated November 28 4:00 PM EST. Delayed by at least 15 minutes.
 

ProMetic Life Sciences Inc

TSX: PLI
Delayed quote

$2.08

Today's change-0.01 -0.48%
Updated November 28 4:00 PM EST. Delayed by at least 15 minutes.

ProMetic Life Sciences Inc down $0.01

ProMetic Life Sciences Inc closed lower Friday, dropping $0.01 or 0.48% to $2.08. Over the last five days, shares have gained 2.46% and 123.66% year to date. Shares have outperformed the S&P TSX by 108.67% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.02
Updated November 28 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-76.51%

ProMetic Life Sciences Inc has a net profit margin of -76.51%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX1.19%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue2465
Total other revenue--------
Total revenue2465
Gross profit1243
Total cost of revenue1222
Total operating expense23-191412
Selling / general / administrative3324
Research & development81066
Depreciation / amortization--------
Interest expense (income), net operating1111
Unusual expense (income)0-800
Other operating expenses, total000-3
Operating income-2123-8-7
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2123-8-7
Income after tax-2123-9-8
Income tax, total0000
Net income-1924-8-7
Total adjustments to net income--------
Net income before extra. items-1924-8-7
Minority interest1110
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1924-8-7
Inc. avail. to common incl. extra. items-1924-8-7
Diluted net income-1924-8-7
Dilution adjustment--00--
Diluted weighted average shares531577528511
Diluted EPS excluding extraordinary itemsvalue per share-0.040.04-0.02-0.01
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.040.03-0.02-0.01